ENTITY
Chugai Pharmaceutical

Chugai Pharmaceutical (4519 JP)

146
Analysis
Health CareJapan
Chugai Pharmaceutical Company Ltd., manufactures and sells pharmaceuticals in the domestic and international markets through its subsidiaries. The Company develops drugs in the fields of cancer, infectious diseases, bone, blood, and circulatory systems. Chugai Pharmaceutical also conducts research studies on drugs with private and public medical research institutions.
more
03 Dec 2018 05:11

Japan: Fortnightly Update - Thanksgiving Rally

THANKSGIVING RALLY - Japan's equity markets have recovered by 2.4% since 16th November and are now 5% above the October 29th low, but the market...

Logo
328 Views
Share
08 Nov 2018 16:30

Japan: Relative Price Score Update - Overbought and Oversold Sectors & Peer Groups

RELATIVE PRICE SCORE - The Relative Price Score (RPS) was introduced in an earlier insight and is a measure of stock price performance relative to...

Logo
484 Views
Share
04 Nov 2018 17:10

Japan Fortnightly Update: Lower Low as Earnings Slow

LOWER LOW - Japanese equities reached a new 52-week low on 29th October but rebounded on the subsequent four trading days to close the...

Logo
381 Views
Share
31 Oct 2018 10:14

Japan: The Demise of The "J Nifty-Fifty"?

THE J 'NIFTY-FIFTY' - In our insight posted on July 1st Japan: Most Overbought & Most Oversold - The Relative Price Score, we highlighted the...

Logo
516 Views
Share
24 Oct 2018 23:03

Chugai 3Q FY18 (YE Dec'18) Results - First Glance

Key highlights Continued brisk export of Actemra (+10.8% to ¥19.5b) and Alecensa (+95.7% to ¥9.2b) to Roche drove Chugai’s 3Q FY18e sales (+4.8% to...

x